The global injection pens market is projected to reach USD 53.3 billion by 2026 from USD 37.6 billion in 2021, at a CAGR of 7.2% during the forecast period. Growing prevalence of chronic diseases, increasing number of regulatory approvals, favourable reimbursement and government support, and technological advancements in injection pens tend to drive the market. Though the market is growing, but factors like alternative drug delivery modes, poor reimbursement scenarios in developing regions and needle anxiety tend to restrain the market growth. Whereas, needle-stick injuries & misuse of injection pens tend to pose a challenge for the market. But, the opportunities for the market lie in the patent expiry of biologics and emerging markets.
Based on product, the disposable injection pen segment holds the largest share during the forecast period.
Based on type, the injection pens market is segmented into reusable and disposable injection pens. In 2020, the disposable injection pens segment accounted for the largest share of the global injection pens market. The large share of the disposable injection pens segment can be attributed to their ease of use and the presence of a built-in cartridge which eliminates the need for manually loading the cartridge, making it more convenient for patients with reduced dexterity or visual impairments.
Based on therapy, the diabetes segment holds the highest growth rate during the forecast period.
Based on therapy, the injection pens market is segmented into diabetes, growth hormone therapy, fertility, osteoporosis, autoimmune diseases, cancer, and other therapies. In 2020, the diabetes segment accounted for the largest share of the injection pens market. The large share of this segment is attributed to the high prevalence of diabetes, increasing awareness about insulin pens among diabetic patients, the rising geriatric population, increased patient support programs by companies & government for diabetes, and the growing availability of insulin pens in the market.
Based on diabetes therapy, the in GLP-1 segment holds the highest growth rate during the forecast period.
Based on type of diabetes therapy, the injection pens market for diabetes therapy is segmented into insulin and GLP-1. In 2020, the GLP-1 segment accounted for the highest growth rate of the injection pens market for diabetes therapy. The growth in the market can be attributed to the higher efficiency of GLP-1 to reduce the blood sugar levels.
Based on end user, the home-care settings segment holds the highest growth rate during the forecast period.
Based on end users, the injection pens market is segmented into home care settings and hospitals & clinics. In 2020, the home care settings segment accounted for the highest growth of the injection pens market. The growing geriatric population, ease of drug administration, increasing prevalence of chronic diseases, technological advancements, and favorable reimbursement scenarios are some of the key factors driving the growth rate of the home care settings market.
Asia Pacific is expected to grow at the highest rate in 2020
Asia Pacific is expected to grow at the highest rate in the forecast year. The rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players, rising demand for advanced technologies, and expansion of private-sector hospitals to rural areas in various countries in the APAC are the major factors driving the growth of the injection pen market in this region.
Break of primary participants was as mentioned below:
- By Company Type - Tier 1-60%, Tier 2-30%, and Tier 3-10%
- By Designation - C-level-30%, Director-level-50%, Others-20%
- By Region - North America-45%, Europe-15%, Asia Pacific-25%, Latin America- 10%, Middle East and Africa-5%
Key players in the Injection pen market
Prominent players in the injection pens market include Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Ypsomed Holding AG (Switzerland), Sanofi (France), Eli Lilly and Company (US), Merck KGaA (Germany), Novartis AG (Switzerland), AstraZeneca plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Owen Mumford (UK), Sulzer Ltd. (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Pfizer (US), Biocon Ltd. (India), Lupin Ltd. (India), Wockhardt Ltd. (India), AptarGroup, Inc. (US), and Gerresheimer AG (Germany). The other players includes Shaily Engineering Plastics Ltd. (India), Bespak Europe Ltd. (UK), SHL Medical AG (Switzerland), Emperra GmbH (Germany), Nemera France SAS, Companion Medical, Inc. (US), and Jiangsu Delfu Medical Device Co., Ltd. (China).
Research Coverage:
The report analyzes the injection pen market and aims at estimating the market size and future growth potential of this market based on various segments such as product type, therapy, end user, and region. The report also includes a product portfolio matrix of various injection pen products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the global injection pen market. The report analyzes this market by product type, therapy, end user and region
- Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global injection pen market
- Market Development: Comprehensive information on the lucrative emerging markets by product type, therapy, end user and region
- Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global injection pen market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global injection pen market.
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions of the Study
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.3.3 Currency
Table 1 Exchange Rates Utilized for the Conversion to Usd
1.4 Stakeholders
1.5 Summary of Changes
2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
Figure 2 Primary Sources
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
Figure 3 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 4 Breakdown of Primary Interviews: Supply-Side and Demand-Side Participants
2.2 Market Size Estimation
Figure 5 Supply-Side Market Size Estimation: Revenue Share Analysis
Figure 6 Revenue Share Analysis Illustration: Sanofi
Figure 7 Revenue Analysis of the Top Four Companies: Injection Pens Market (2020)
Figure 8 CAGR Projections from the Analysis of Drivers, Restraints, Opportunities, and Challenges of the Injection Pens Market (2021-2026)
Figure 9 CAGR Projections: Supply-Side Analysis
Figure 10 Top-Down Approach
2.3 Market Breakdown & Data Triangulation
Figure 11 Market Data Triangulation Methodology
2.4 Market Share Analysis
2.5 Assumptions for the Study
2.6 Risk Assessment
Table 2 Risk Assessment: Injection Pens Market
2.7 Limitations
2.7.1 Methodology-Related Limitations
2.7.2 Scope-Related Limitations
3 Executive Summary
Figure 12 Injection Pens Market, by Type, 2021 Vs. 2026 (USD Million)
Figure 13 Injection Pens Market, by Therapy, 2021 Vs. 2026 (USD Million)
Figure 14 Injection Pens Market for Diabetes Therapy, by Type, 2021 Vs. 2026 (USD Million)
Figure 15 Injection Pens Market, by End-user, 2021 Vs. 2026 (USD Million)
Figure 16 Geographical Snapshot of the Injection Pens Market
4 Premium Insights
4.1 Injection Pens Market Overview
Figure 17 Growing Prevalence of Chronic Diseases to Drive Market Growth
4.2 Asia-Pacific: Injection Pens Market, by Therapy and Country (2020)
Figure 18 Diabetes Segment Accounted for the Largest Share of the Asia-Pacific Injection Pens Market in 2020
4.3 Injection Pens Market: Geographic Growth Opportunities
Figure 19 China to Register the Highest Growth Rate in the Injection Pens Market During the Forecast Period
4.4 Injection Pens Market, by Region, 2021-2026
Figure 20 North America Will Continue to Dominate the Global Injection Pens Market in 2026
4.5 Injection Pens Market: Developed Vs. Developing Markets
Figure 21 Developing Markets to Register Higher Growth During the Forecast Period
5 Market Overview
5.1 Market Dynamics
Figure 22 Injection Pens Market: Drivers, Restraints, Opportunities, and Challenges
5.1.1 Market Drivers
5.1.1.1 Growing Prevalence of Chronic Diseases
Figure 23 Number of People with Chronic Diseases in the US, 1995-2030 (Million Individuals)
Figure 24 Estimated Diabetic Population, by Region, 2019 Vs. 2030 Vs. 2040 (Million)
Figure 25 Global Cancer Incidence, 2015-2040 (Million)
5.1.1.2 Increasing Number of Regulatory Approvals
5.1.1.3 Favorable Reimbursement and Government Support
5.1.1.4 Technological Advancements in Injection Pens
Table 3 Market Drivers: Impact Analysis
5.1.2 Market Restraints
5.1.2.1 Preference for Alternative Drug Delivery Modes
5.1.2.2 Poor Reimbursement Scenario in Developing Countries
5.1.2.3 Needle Anxiety
Table 4 Market Restraints: Impact Analysis
5.1.3 Market Opportunities
5.1.3.1 Patent Expiry of Biologics to Drive the Demand for Biosimilars
5.1.3.2 Growth Opportunities in Emerging Markets
Figure 26 Diabetes Population in Developing Countries, 2020 Vs. 2040 (Million)
Table 5 Rising Income Levels in Emerging Countries
Table 6 Market Opportunities: Impact Analysis
5.1.4 Market Challenges
5.1.4.1 Needlestick Injuries and Misuse of Injection Pens
Table 7 Market Challenges: Impact Analysis
5.2 Value Chain Analysis
Figure 27 Injection Pens Market: Value Chain Analysis
5.3 Supply Chain Analysis
Figure 28 Injection Pens Market: Supply Chain Analysis
5.4 Pricing Analysis
Table 8 Pricing of Injection Pens Available in the Market
5.5 Ecosystem Market Map
Figure 29 Injection Pens Market: Ecosystem Market Map
5.6 Porter's Five Forces Analysis
Table 9 Injection Pens Market: Porter's Five Forces Analysis
5.6.1 Intensity of Competitive Rivalry
5.6.2 Bargaining Power of Suppliers
5.6.3 Bargaining Power of Buyers
5.6.4 Threat of Substitutes
5.6.5 Threat of New Entrants
5.7 Regulatory Analysis
5.7.1 North America
5.7.1.1 US
Table 10 US Fda: Medical Device Classification
Table 11 Us: Medical Device Regulatory Approval Process
5.7.1.2 Canada
Table 12 Canada: Medical Device Regulatory Approval Process
Figure 30 Canada: Class Ii Medical Device Approval Process
5.7.2 Europe
Figure 31 Europe: Ce Approval Process for Class Iia Medical Devices
5.7.3 Asia-Pacific
5.7.3.1 Japan
Table 13 Japan: Medical Device Classification Under Pmda
5.7.3.2 China
Table 14 China: Regulatory Bodies Appointed for Medical Device Approval
Table 15 China: Classification of Medical Devices
5.7.3.3 India
5.8 Impact of COVID-19 on the Injection Pens Market
5.9 Patent Analysis
5.9.1 Patent Publication Trends for Injection Pens
Figure 32 Patent Publication Trends (January 2011-September 2021)
5.9.2 Insights: Jurisdiction and Top Applicant Analysis
Figure 33 Top Applicants and Owners (Companies/Institutes) for Injection Pen Patents (January 2011-September 2021)
Figure 34 Top Applicant Countries/Regions for Injection Pen Patents (January 2011-September 2021)
5.10 Technology Analysis
Table 16 Pen Injectors Classification
5.10.1 Key Technologies
5.10.1.1 Dose Setting and Needle Actuation
5.10.1.2 Pen Injector Material
5.10.2 Complementary Technologies
5.10.2.1 In-Built Dose and Time Log
5.10.2.2 Wireless Connectivity
5.10.2.3 Smartpen Injectors
5.10.2.4 Smart Caps and Attachments
5.10.2.5 Injector Temperature Monitoring
5.10.3 Adjacent Technologies
5.10.3.1 Autoinjectors
5.10.3.2 Insulin Pumps
6 Injection Pens Market, by Type
6.1 Introduction
Table 17 Injection Pens Market, by Type, 2019-2026 (USD Million)
6.2 Disposable Injection Pens
6.2.1 High Patient Compliance and Ease of Handling to Drive the Adoption of Disposable Injection Pens
Table 18 Disposable Injection Pens Available in the Market
Table 19 Disposable Injection Pens Market, by Country, 2019-2026 (USD Million)
6.3 Reusable Injection Pens
6.3.1 Reusable Injection Pens to Register the Highest Growth Due to Technological Advancements
Table 20 Reusable Injection Pens Available in the Market
Table 21 Reusable Injection Pens Market, by Country, 2019-2026 (USD Million)
7 Injection Pens Market, by Therapy
7.1 Introduction
Table 22 Injection Pens Market, by Therapy, 2019-2026 (USD Million)
7.2 Diabetes
Table 23 Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 24 Injection Pens Market for Diabetes Therapy, by Country, 2019-2026 (USD Million)
7.2.1 Insulin
7.2.1.1 Rising Prevalence of Diabetes is Driving the Growth of this Market
Table 25 Examples of Insulin Injection Pens
Table 26 Injection Pens Market for Insulin Therapy, by Country, 2019-2026 (USD Million)
7.2.2 Glucagon-Like Peptide-1 (Glp-1) Therapy
7.2.2.1 Strong Focus of Major Pharmaceutical Companies to Introduce Glp-1 Drugs to Drive Market Growth
Table 27 Examples of Glp-1 Injection Pens
Table 28 Injection Pens Market for Glp-1 Therapy, by Country, 2019-2026 (USD Million)
7.3 Growth Hormone Therapy
7.3.1 Development of Sustained-Release Growth Hormone Formulations for Reducing Injection Frequency to Restrain the Market Growth
Table 29 Examples of Injection Pens for Growth Hormone Therapy
Table 30 Injection Pens Market for Growth Hormone Therapy, by Country, 2019-2026 (USD Million)
7.4 Osteoporosis
7.4.1 Growing Prevalence of Osteoporosis in Geriatric Patients and Women to Drive Market Growth
Table 31 Examples of Injection Pens for Osteoporosis Therapy
Table 32 Injection Pens Market for Osteoporosis Therapy, by Country, 2019-2026 (USD Million)
7.5 Fertility
7.5.1 Decrease in Fertility Rate Has Resulted in the Increased Use of Injection Pens
Table 33 Examples of Injection Pens for Fertility Therapy
Table 34 Injection Pens Market for Fertility Therapy, by Country, 2019-2026 (USD Million)
7.6 Cancer
7.6.1 Rising Prevalence of Cancer to Drive Market Growth
Table 35 Examples of Injection Pens for Cancer Therapy
Table 36 Injection Pens Market for Cancer Therapy, by Country, 2019-2026 (USD Million)
7.7 Autoimmune Diseases
7.7.1 Developments in Therapies and Delivery Devices for the Treatment of Ms to Boost the Market Growth
Table 37 Examples of Injection Pens for Multiple Sclerosis and Psoriasis Therapy
Table 38 Injection Pens Market for Autoimmune Disease Therapy, by Country, 2019-2026 (USD Million)
7.8 Other Therapies
Table 39 Injection Pens Market for Other Therapies, by Country, 2019-2026 (USD Million)
8 Injection Pens Market, by End-user
8.1 Introduction
Table 40 Injection Pens Market, by End-user, 2019-2026 (USD Million)
8.2 Home Care Settings
8.2.1 Home Care Settings Are the Largest End-users of Injection Pens
Table 41 Injection Pens Market for Home Care Settings, by Country, 2019-2026 (USD Million)
8.3 Hospitals & Clinics
8.3.1 Growing Incidence of Needlestick Injuries and Unsafe Injection Practices Have Increased the Demand for Injection Pens
Table 42 Injection Pens Market for Hospitals & Clinics, by Country, 2019-2026 (USD Million)
9 Injection Pens Market, by Region
9.1 Introduction
Table 43 Injection Pens Market, by Region, 2019-2026 (USD Million)
Figure 35 Emerging Countries Are Expected to Witness Higher Growth in the Forecast Period
9.2 North America
Figure 36 North America: Injection Pens Market Snapshot
Table 44 Injection Pens Market, by Country, 2019-2026 (USD Million)
Table 45 North America: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 46 North America: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 47 North America: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 48 North America: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.2.1 US
9.2.1.1 the US Dominates the North American Injection Pens Market
Figure 37 Total Fertility Rate in the US Population (1990-2020)
Table 49 Us: Key Macroindicators
Table 50 Us: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 51 Us: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 52 Us: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 53 Us: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.2.2 Canada
9.2.2.1 Unfavorable Regulatory Processes in Canada to Restrain the Market Growth
Table 54 Canada: Key Macroindicators
Table 55 Canada: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 56 Canada: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 57 Canada: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 58 Canada: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.3 Europe
Table 59 Europe: Injection Pens Market, by Country, 2019-2026 (USD Million)
Table 60 Europe: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 61 Europe: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 62 Europe: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 63 Europe: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.3.1 Germany
9.3.1.1 High Diabetes Expenditure and Reimbursement for Injection Pens to Drive the Market in Germany
Table 64 Germany: Key Macroindicators
Table 65 Germany: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 66 Germany: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 67 Germany: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 68 Germany: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.3.2 France
9.3.2.1 Misuse of Injection Pens Pose a Threat to the Growth of this Market
Table 69 France: Key Macroindicators
Table 70 France: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 71 France: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 72 France: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 73 France: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.3.3 UK
9.3.3.1 Nhs Support and Access to Cost-Effective Injection Pens Are Likely to Drive the Market in the UK
Table 74 Uk: Key Macroindicators
Table 75 Uk: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 76 Uk: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 77 Uk: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 78 Uk: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.3.4 Italy
9.3.4.1 Regional Variation in Terms of Coverage and Benefits to Hinder the Market Growth
Table 79 Italy: Key Macroindicators
Table 80 Italy: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 81 Italy: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 82 Italy: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 83 Italy: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.3.5 Spain
9.3.5.1 Supportive Regulations Mandating the Use of Safety Injection Pens to Boost the Growth of the Spanish Market
Table 84 Spain: Key Macroindicators
Table 85 Spain: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 86 Spain: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 87 Spain: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 88 Spain: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.3.6 Benelux
9.3.6.1 Increasing Awareness About Injection Pen Devices to Drive Market Growth
Table 89 Benelux: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 90 Benelux: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 91 Benelux: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 92 Benelux: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.3.7 Rest of Europe
Table 93 RoE: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 94 RoE: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 95 RoE: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 96 RoE: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.4 Asia-Pacific
Figure 38 Asia-Pacific: Injection Pens Market Snapshot
Table 97 APAC: Injection Pens Market, by Country, 2019-2026 (USD Million)
Table 98 APAC: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 99 APAC: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 100 APAC: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 101 APAC: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.4.1 Japan
9.4.1.1 High Diabetes Incidence and Supportive Reimbursement Policies to Drive the Market Growth in Japan
Table 102 Japan: Key Macroindicators
Table 103 Japan: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 104 Japan: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 105 Japan: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 106 Japan: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.4.2 China
9.4.2.1 Large Patient Population and Healthcare Infrastructure Improvements to Drive the Market Growth in China
Table 107 China: Key Macroindicators
Table 108 China: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 109 China: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 110 China: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 111 China: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.4.3 India
9.4.3.1 Rising Prevalence of Obesity to Drive Market Growth
Table 112 India: Key Macroindicators
Table 113 India: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 114 India: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 115 India: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 116 India: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.4.4 Southeast Asia
9.4.4.1 Growing Awareness About Diabetes to Drive the Adoption of Injection Pens
Figure 39 Diabetes Prevalence in Southeast Asia (2019)
Figure 40 Healthcare Expenditure (% of GDP) in Southeast Asia (2018)
Figure 41 Geriatric Population (% of the Total Population), 2019
Table 117 Southeast Asia: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 118 Southeast Asia: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 119 Southeast Asia: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 120 Southeast Asia: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.4.5 Rest of APAC
Table 121 Roapac: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 122 Roapac: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 123 Roapac: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 124 Roapac: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.5 Latin America
Table 125 Latam: Injection Pens Market, by Country, 2019-2026 (USD Million)
Table 126 Latam: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 127 Latam: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 128 Latam: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 129 Latam: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.5.1 Brazil
9.5.1.1 Brazil Dominates the Injection Pens Market in Latin America
Table 130 Brazil: Key Macroindicators
Table 131 Brazil: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 132 Brazil: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 133 Brazil: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 134 Brazil: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.5.2 Mexico
9.5.2.1 Increasing Incidence of Lifestyle-Related Disorders to Drive Market Growth in Mexico
Table 135 Mexico: Key Macroindicators
Table 136 Mexico: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 137 Mexico: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 138 Mexico: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 139 Mexico: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.5.3 Rest of Latin America
Figure 42 Health Expenditure (% of GDP) in Latin American Countries, 2018
Table 140 Rolatam: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 141 Rolatam: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 142 Rolatam: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 143 Rolatam: Injection Pens Market, by End-user, 2019-2026 (USD Million)
9.6 Middle East & Africa
9.6.1 Initiatives to Enhance Healthcare Accessibility to Support Market Growth
Table 144 Mea: Injection Pens Market, by Type, 2019-2026 (USD Million)
Table 145 Mea: Injection Pens Market, by Therapy, 2019-2026 (USD Million)
Table 146 Mea: Injection Pens Market for Diabetes Therapy, by Type, 2019-2026 (USD Million)
Table 147 Mea: Injection Pens Market, by End-user, 2019-2026 (USD Million)
10 Competitive Landscape
10.1 Overview
10.2 Key Player Strategies
10.3 Revenue Share Analysis of the Top Market Players
Figure 43 Revenue Analysis of the Top Players in the Injection Pens Market
10.4 Market Share Analysis
Figure 44 Injection Pens Market Share Analysis, by Key Player, 2020
10.5 Market Ranking Analysis of Oem Companies
Figure 45 Injection Pens Market Ranking, by Oem Company (2020)
10.6 Company Evaluation Quadrant
10.6.1 Stars
10.6.2 Emerging Leaders
10.6.3 Pervasive Players
10.6.4 Participants
Figure 46 Injection Pens Market: Company Evaluation Quadrant (2020)
10.7 Company Evaluation Quadrant for Start-Ups
10.7.1 Progressive Companies
10.7.2 Dynamic Companies
10.7.3 Starting Blocks
10.7.4 Responsive Companies
Figure 47 Injection Pens Market: Company Evaluation Quadrant for Start-Ups (2020)
10.8 Company Product Footprint
Table 148 Product Portfolio Analysis: Injection Pens Market, by Type
Table 149 Product Portfolio Analysis: Injection Pens Market, by Therapy
10.9 Geographic Footprint of Major Players in the Injection Pens Market
Table 150 Geographic Revenue Mix: Injection Pens Market (2020)
10.10 Competitive Scenario
10.10.1 Product Launches
Table 151 Product Launches (January 2018-September 2021)
10.10.2 Other Developments
Table 152 Other Developments (January 2018-September 2021)
11 Company Profiles
11.1 Key Players
(Business Overview, Products Offered, Recent Developments, and Analyst's View)*
11.1.1 Novo Nordisk A/S
Table 153 Novo Nordisk A/S: Business Overview
Figure 48 Novo Nordisk A/S: Company Snapshot (2020)
11.1.2 Becton, Dickinson and Company
Table 154 Becton, Dickinson and Company: Business Overview
Figure 49 Becton, Dickinson and Company: Company Snapshot (2020)
11.1.3 Ypsomed Holding Ag
Table 155 Ypsomed Holding Ag: Business Overview
Figure 50 Ypsomed Holding Ag: Company Snapshot (2020)
11.1.4 Sanofi
Table 156 Sanofi: Business Overview
Figure 51 Sanofi: Company Snapshot (2020)
11.1.5 Eli Lilly and Company
Table 157 Eli Lilly and Company: Business Overview
Figure 52 Eli Lilly and Company: Company Snapshot (2020)
11.1.6 Merck Kgaa
Table 158 Merck Kgaa: Business Overview
Figure 53 Merck Kgaa: Company Snapshot (2020)
11.1.7 Astrazeneca
Table 159 Astrazeneca: Business Overview
Figure 54 Astrazeneca: Company Snapshot (2020)
11.1.8 F. Hoffmann-La Roche Ltd.
Table 160 F. Hoffmann-La Roche Ltd.: Business Overview
Figure 55 F. Hoffmann-La Roche Ltd.: Company Snapshot (2020)
11.1.9 Owen Mumford
Table 161 Owen Mumford: Business Overview
11.1.10 Sulzer Ltd.
Table 162 Sulzer Ltd.: Business Overview
11.1.11 Sun Pharmaceutical Industries Ltd.
Table 163 Sun Pharmaceutical Industries Ltd: Business Overview
Figure 56 Sun Pharmaceutical Industries Ltd.: Company Snapshot (2020)
11.1.12 Pfizer
Table 164 Pfizer: Business Overview
Figure 57 Pfizer: Company Snapshot (2020)
11.1.13 Biocon Ltd.
Table 165 Biocon Ltd.: Business Overview
Figure 58 Biocon Ltd.: Company Snapshot (2020)
11.1.14 Lupin Ltd.
Table 166 Lupin Ltd.: Business Overview
Figure 59 Lupin Ltd.: Company Snapshot (2020)
11.1.15 Wockhardt Ltd.
Table 167 Wockhardt Ltd.: Business Overview
Figure 60 Wockhardt Ltd.: Company Snapshot (2020)
11.1.16 Aptargroup, Inc.
Table 168 Aptargroup, Inc.: Business Overview
Figure 61 Aptargroup, Inc.: Company Snapshot (2020)
11.1.17 Novartis Ag
Table 169 Novartis Ag: Business Overview
Figure 62 Novartis Ag: Company Snapshot (2020)
11.1.18 Gerresheimer Ag
Table 170 Gerresheimer Ag: Business Overview
Figure 63 Gerresheimer Ag: Company Snapshot (2020)
11.2 Other Players
11.2.1 Shaily Engineering Plastics Ltd.
Table 171 Shaily Engineering Plastics Ltd.: Business Overview
11.2.2 Bespak Europe Ltd.
Table 172 Bespak Europe Ltd.: Business Overview
11.2.3 Shl Medical Ag
Table 173 Shl Medical Ag: Business Overview
11.2.4 Emperra Gmbh
Table 174 Emperra Gmbh: Business Overview
11.2.5 Nemera France Sas
Table 175 Nemera France Sas: Business Overview
11.2.6 Companion Medical, Inc.
Table 176 Companion Medical, Inc.: Business Overview
11.2.7 Jiangsu Delfu Medical Device Co. Ltd.
Table 177 Jiangsu Delfu Medical Device Co. Ltd.: Business Overview
* Business Overview, Products Offered, Recent Developments, and Analyst's View Might Not be Captured in Case of Unlisted Companies.
12 Appendix
12.1 Discussion Guide
12.2 Knowledge Store: The Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details
Executive Summary
Companies Mentioned
- Aptargroup, Inc.
- Astrazeneca
- Becton, Dickinson and Company
- Bespak Europe Ltd.
- Biocon Ltd.
- Companion Medical, Inc.
- Eli Lilly and Company
- Emperra Gmbh
- F. Hoffmann-La Roche Ltd.
- Gerresheimer Ag
- Jiangsu Delfu Medical Device Co. Ltd.
- Lupin Ltd.
- Merck Kgaa
- Nemera France Sas
- Novartis Ag
- Novo Nordisk A/S
- Owen Mumford
- Pfizer
- Sanofi
- Shaily Engineering Plastics Ltd.
- SHL Medical Ag
- Sulzer Ltd.
- Sun Pharmaceutical Industries Ltd.
- Wockhardt Ltd.
- Ypsomed Holding Ag
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 225 |
| Published | November 2021 |
| Forecast Period | 2021 - 2026 |
| Estimated Market Value ( USD | $ 37.6 Billion |
| Forecasted Market Value ( USD | $ 53.3 Billion |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
